Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ai |
RCV002223572 | SCV002501297 | uncertain significance | not provided | 2022-02-04 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003089178 | SCV003027791 | uncertain significance | Insulin-dependent diabetes mellitus secretory diarrhea syndrome | 2023-08-30 | criteria provided, single submitter | clinical testing | This sequence change replaces phenylalanine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 324 of the FOXP3 protein (p.Phe324Val). This variant is not present in population databases (gnomAD no frequency). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. ClinVar contains an entry for this variant (Variation ID: 1677891). This variant has not been reported in the literature in individuals affected with FOXP3-related conditions. |
Ce |
RCV002223572 | SCV005042372 | uncertain significance | not provided | 2024-04-01 | criteria provided, single submitter | clinical testing | FOXP3: PM2 |